BioCardia, Inc. (BCDA)
BioCardia has a market cap or net worth of $41.69 million. The enterprise value is $36.73 million.
The next earnings date is Tuesday, May 9, 2023, after market close.
|Estimated Earnings Date||May 9, 2023|
BioCardia has 20.05 million shares outstanding. The number of shares has increased by 4.56% in one year.
|Shares Change (YoY)||+4.56%|
|Shares Change (QoQ)||+1.09%|
|Owned by Insiders (%)||33.25%|
|Owned by Institutions (%)||17.96%|
|EV / Earnings||n/a|
|EV / Sales||27.72|
|EV / EBITDA||n/a|
|EV / EBIT||n/a|
|EV / FCF||n/a|
The company has a current ratio of 1.94, with a Debt / Equity ratio of 0.42.
|Debt / Equity||0.42|
|Debt / EBITDA||n/a|
|Debt / FCF||n/a|
Return on equity (ROE) is -172.70% and return on invested capital (ROIC) is -1,321.20%.
|Return on Equity (ROE)||-172.70%|
|Return on Assets (ROA)||-100.70%|
|Return on Capital (ROIC)||-1,321.20%|
|Revenue Per Employee||$47,321|
|Profits Per Employee||-$440,714|
|Effective Tax Rate||n/a|
Stock Price Statistics
The stock price has decreased by -2.09% in the last 52 weeks. The beta is 1.07, so BioCardia's price volatility has been similar to the market average.
|52-Week Price Change||-2.09%|
|50-Day Moving Average||2.22|
|200-Day Moving Average||1.90|
|Average Volume (30 Days)||31,111|
Short Selling Information
The latest short interest is 37,538, so 0.19% of the outstanding shares have been sold short.
|Short Previous Month||35,811|
|Short % of Shares Out||0.19%|
|Short % of Float||0.33%|
|Short Ratio (days to cover)||1.58|
In the last 12 months, BioCardia had revenue of $1.33 million and -$12.34 million in losses. Loss per share was -$0.71.
|Loss Per Share||-$0.71|
The company has $6.67 million in cash and $1.70 million in debt, giving a net cash position of $4.97 million or $0.25 per share.
|Cash & Cash Equivalents||6.67M|
|Net Cash Per Share||$0.25|
|Equity / Book Value||4.10M|
|Book Value Per Share||0.20|
In the last 12 months, operating cash flow was -$10.54 million and capital expenditures -$109,000, giving a free cash flow of -$10.65 million.
|Operating Cash Flow||-10.54M|
|Free Cash Flow||-10.65M|
|FCF Per Share||-$0.60|
Gross margin is 100.00%, with operating and profit margins of -931.62% and -931.32%.
Dividends & Yields
BioCardia does not appear to pay any dividends at this time.
|Dividend Per Share||n/a|
|Dividend Growth (YoY)||n/a|
The average price target for BioCardia is $7.65, which is 271.36% higher than the current price. The consensus rating is "Buy".
|Price Target Difference||271.36%|
|Revenue Growth Forecast (5Y)||73.13%|
|EPS Growth Forecast (5Y)||-12.06%|
The last stock split was on June 6, 2019. It was a reverse split with a ratio of 1:9.
|Last Split Date||Jun 6, 2019|